Dulaglutide, a groundbreaking glucagon-like peptide-1 (GLP-1) receptor agonist, offers a crucial role in managing type 2 diabetes. The increasing requirement for this medication has spurred the development of US-based https://saadoxeo335510.arwebo.com/60829359/us-based-dulaglutide-synthesis-advancing-diabetes-treatment